More on SPRB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $53.78 |
|
|||
| Open | $52.13 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $55.99 | ||||
| Day Low | $51.40 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 25,144 | ||||
- Spruce Biosciences to Present at Upcoming Investor Conferences in March
- Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
- Spruce Biosciences, Inc. (SPRB) PT Lowered to $200 at H.C. Wainwright
- Form SCHEDULE 13D/A SPRUCE BIOSCIENCES, INC. Filed by: Carlyle Group Inc.
- Spruce Biosciences, Inc. (SPRB) PT Lowered to $180 at Citizens
- Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
- Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: ADAR1 Capital Management, LLC
- Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: Alyeska Investment Group, L.P.
- Form SCHEDULE 13G/A SPRUCE BIOSCIENCES, INC. Filed by: CITADEL ADVISORS LLC
- Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Entities mentioned with SPRB
- Twitter | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13D | View Related Stories »
- Show More...
